• 8940 Citations
  • 50 h-Index
19932018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Chemoprevention Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Mouth Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2018

1 Citations

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Borghaei, H., Langer, C. J., Gadgeel, S., Papadimitrakopoulou, V. A., Patnaik, A., Powell, S. F., Gentzler, R. D., Martins, R. G., Stevenson, J. P., Jalal, S. I., Panwalkar, A., Chih-Hsin Yang, J., Gubens, M., Sequist, L. V., Awad, M. M., Fiore, J., Saraf, S., Keller, S. M. & Gandhi, L., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Survival
Therapeutics
3 Citations

CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-l1 blockade

Chen, L., Diao, L., Yang, Y., Yi, X., Rodriguez, B. L., Li, Y., Villalobos, P. A., Cascone, T., Liu, X., Tan, L., Lorenzi, P. L., Huang, A., Zhao, Q., Peng, D., Fradette, J. J., Peng, D. H., Ungewiss, C., Roybal, J., Tong, P., Oba, J. & 19 othersSkoulidis, F., Peng, W., Carter, B., Gay, C. M., Fan, Y., Class, C. A., Zhu, J., Rodriguez-Canales, J., Kawakami, M., Byers, L. A., Woodman, S. E., Papadimitrakopoulou, V. A., Dmitrovsky, E., Wang, J., Ullrich, S. E., Wistuba, I. I., Heymach, J. V., Qin, F. X. F. & Gibbons, D. L., Sep 1 2018, In : Cancer discovery. 8, 9, p. 1156-1175 20 p.

Research output: Contribution to journalArticle

Tumor Escape
Immunosuppression
Purinergic P1 Receptors
Neoplasms
T-Lymphocytes

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

Nong, J., Gong, Y., Guan, Y., Yi, X., Yi, Y., Chang, L., Yang, L., Lv, J., Guo, Z., Jia, H., Chu, Y., Liu, T., Chen, M., Byers, L., Roarty, E., Lam, V. K., Papadimitrakopoulou, V. A., Wistuba, I. I., Heymach, J. V., Glisson, B. S. & 7 othersLiao, Z., Lee, J-K. J., Futreal, P. A., Zhang, S., Xia, X., Zhang, J. & Wang, J., Dec 1 2018, In : Nature communications. 9, 1, 3114.

Research output: Contribution to journalArticle

tumor
cancer
genomics
DNA
mutation
4 Citations

CNS efficacy of osimertinib in patients with T790M-positive advanced non–small-cell lung cancer: Data from a randomized Phase III trial (Aura3)

Wu, Y. L., Ahn, M. J., Garassino, M. C., Han, J. Y., Katakami, N., Kim, H. R., Hodge, R., Kaur, P., Brown, A. P., Ghiorghiu, D., Papadimitrakopoulou, V. A. & Mok, T. S. K., Sep 10 2018, In : Journal of Clinical Oncology. 36, 26, p. 2702-2709 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Pemetrexed
Platinum
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases

Concomitant targeting of the mTOR/MAPK pathways: Novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer

Ruder, D., Papadimitrakopoulou, V. A., Shien, K., Behrens, M. D. C., Kalhor, N., Chen, H., Shen, L., Lee, J-K. J., Hong, W. K., Tang, X., Girard, L., Minna, J. D., Diao, L., Wang, J., Mino, B., Villalobos, P., Rodriguez-Canales, J., Hanson, N. E., Sun, J., Miller, V. & 6 othersGreenbowe, J., Frampton, G., Herbst, R. S., Baladandayuthapani, V., Wistuba, I. I. & Izzo, G. J., Sep 1 2018, In : Oncotarget. 9, 74, p. 33995-34008 14 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Biodiversity
Therapeutics
Lung Neoplasms
Clinical Trials